1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry.

OBJECTIVES The 1-year data from the international ADVANCE (Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care) Registry of patients undergoing coronary computed tomography angiography (CTA) was used to evaluate the relationship of fractional flow reserve derived from coronary CTA (FFRCT) with downstream care and clinical outcomes. BACKGROUND Guidelines for management of chest pain using noninvasive imaging pathways are based on short- to intermediate-term outcomes. METHODS Patients (N = 5,083) evaluated for clinically suspected coronary artery disease and in whom atherosclerosis was identified by coronary CTA were prospectively enrolled at 38 international sites from July 15, 2015, to October 20, 2017. Demographics, symptom status, coronary CTA and FFRCT findings and resultant site-based treatment plans, and clinical outcomes through 1 year were recorded and adjudicated by a blinded core laboratory. Major adverse cardiac events (MACE), death, myocardial infarction (MI), and acute coronary syndrome leading to urgent revascularization were captured. RESULTS At 1 year, 449 patients did not have follow-up data. Revascularization occurred in 1,208 (38.40%) patients with an FFRCT ≤0.80 and in 89 (5.60%) with an FFRCT >0.80 (relative risk [RR]: 6.87; 95% confidence interval [CI]: 5.59 to 8.45; p < 0.001). MACE occurred in 55 patients, 43 events occurred in patients with an FFRCT ≤0.80 and 12 occurred in those with an FFRCT >0.80 (RR: 1.81; 95% CI: 0.96 to 3.43; p = 0.06). Time to first event (all-cause death or MI) occurred in 38 (1.20%) patients with an FFRCT ≤0.80 compared with 10 (0.60%) patients with an FFRCT >0.80 (RR: 1.92; 95% CI: 0.96 to 3.85; p = 0.06). Time to first event (cardiovascular death or MI) occurred cardiovascular death or MI occurred more in patients with an FFRCT ≤0.80 compared with patients with an FFRCT >0.80 (25 [0.80%] vs. 3 [0.20%]; RR: 4.22; 95% CI: 1.28 to 13.95; p = 0.01). CONCLUSIONS The 1-year outcomes from the ADVANCE FFRCT Registry show low rates of events in all patients, with less revascularization and a trend toward lower MACE and significantly lower cardiovascular death or MI in patients with a negative FFRCT compared with patients with abnormal FFRCT values. (Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Wave [ADVANCE]; NCT02499679).

[1]  Jeroen J. Bax,et al.  Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry , 2018, European heart journal.

[2]  D. Andreini,et al.  Selective Referral Using CCTA Versus Direct Referral for Individuals Referred to Invasive Coronary Angiography for Suspected CAD: A Randomized, Controlled, Open-Label Trial. , 2019, JACC. Cardiovascular imaging.

[3]  C. Terkelsen,et al.  Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease. , 2018, Journal of the American College of Cardiology.

[4]  E. V. van Beek,et al.  Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study , 2019, Journal of the American College of Cardiology.

[5]  Jeroen J. Bax,et al.  Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFRCT in Coronary Care (ADVANCE) registry. , 2017, Journal of cardiovascular computed tomography.

[6]  E. V. van Beek,et al.  Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction , 2018, The New England journal of medicine.

[7]  E. Yow,et al.  A selection of recent, original research papers , 2015, Journal of Nuclear Cardiology.

[8]  B. Meyers,et al.  The American Association for Thoracic Surgery , 2016 .

[9]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI for stable coronary artery disease. , 2014, The New England journal of medicine.

[10]  Udo Hoffmann,et al.  Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. , 2017, JACC. Cardiovascular imaging.

[11]  Pamela S Douglas,et al.  Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.

[12]  Charles A. Taylor,et al.  Comparison of Coronary Computed Tomography Angiography, Fractional Flow Reserve, and Perfusion Imaging for Ischemia Diagnosis. , 2019, Journal of the American College of Cardiology.

[13]  Matthias Gutberlet,et al.  Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study , 2015, European heart journal.